Business
- mRNA licensing agreements double with million-dollar deals
07 Oct, 2024 - Europe’s Pneumococcal Vaccine Market Size Set to Achieve 2.9 Billion By 2032, Growing at 5.8% CAGR
07 Oct, 2024 - Parts of Tamil Nadu facing DPT vaccine shortage
05 Oct, 2024 - ASPR takes next steps to prepare vaccine against H5 influenza
04 Oct, 2024 - 2024 Research | Vaccine Delivery Devices Market Poised for Remarkable Growth, Expected to Reach $9.45 Billion by 2028
04 Oct, 2024 - Alnylam’s Concedes Its Patent Infringement Case Against Moderna’s COVID-19 Vaccine
03 Oct, 2024 - Isothermal Boxes For Vaccines Market Consumer Segmentation
03 Oct, 2024 - Novavax stock falls after comments on report (NASDAQ:NVAX)
03 Oct, 2024 - Valneva Announces Investor Day to Showcase Vaccine Pipeline
03 Oct, 2024 - Novavax (NVAX) Stock Rises 19% After FDA Approval for Updated COVID-19 Vaccine
03 Oct, 2024 - mRNA Industry: Growing Beyond COVID Vaccines
03 Oct, 2024 - CEPI invests over $250m to develop Lassa fever vaccine
02 Oct, 2024 - LenioBio Collaborates with ReciBioPharm to Scale Up ALiCE® Technology and Expedite Vaccine Production
02 Oct, 2024 - Well Prepared to Tackle New Pandemics
02 Oct, 2024 - Canada won’t be ordering Novavax’s updated COVID-19 vaccine, cites low demand
01 Oct, 2024 - Evaxion Biotech Partners with Merck for Vaccine Development
01 Oct, 2024 - Moderna (MRNA) and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan
01 Oct, 2024 - DULAS’S NEW REFRIGERATION RANGE ADDRESSES STAGGERING VACCINE LOSSES CAUSED BY COLD CHAIN FAILURES
01 Oct, 2024 - WHO’s MRNA Vaccine Hub Faces Uncertainty And Shortfalls
30 Sep, 2024
0 Comments